CLIFTON R. LADUANE (CFO, Secretary & Treasurer) purchased 24.9% of their position (2.74K shares) of ZEVRA THERAPEUTICS, INC. on the open market
Open‑market purchase worth $13.6K — a significant purchase. The strongest form of insider conviction signal.
P · 3 purchases
Filed: 5/18/2023ACC: 0001437749-23-015140
Officer· CFO, Secretary & Treasurer
Since Oct 2018
+2.74K
Net shares
Net buyer
$13.6K
Total acquired
3
Open market trades
3B · 0S
3
Total transactions
2.74K acquired
Non-Derivative Transactions3
Common Stock
Direct
Shares
+51.00
Price / share
$4.94
Trade value
$251.94
% of position
0.5%
5/18/2023
11K→11.05K
Common Stock
Direct
Shares
+2K
Price / share
$4.95
Trade value
$9.90K
% of position
18.1%
5/18/2023
11.05K→13.05K
Common Stock
Direct
Shares
+689.00
Price / share
$4.95
Trade value
$3.41K
% of position
5.3%
5/18/2023
13.05K→13.74K
Total
Net shares
+2.74K
Net value
$13.56K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/18/2023 | P · Purchase | +51.00 | $4.94 | $251.94 | 0.5% | 11K | 11.05K |
| Common Stock Direct | 5/18/2023 | P · Purchase | +2K | $4.95 | $9.90K | 18.1% | 11.05K | 13.05K |
| Common Stock Direct | 5/18/2023 | P · Purchase | +689.00 | $4.95 | $3.41K | 5.3% | 13.05K | 13.74K |
| Total | +2.74K | $13.56K | ||||||
Derivative Transactions0
No derivative transactions reported